ASP Isotopes Inc. Files 8-K Report

Ticker: ASPI · Form: 8-K · Filed: Oct 14, 2025 · CIK: 1921865

Sentiment: neutral

Topics: 8-K, filing, sec

TL;DR

ASP Isotopes filed an 8-K, check for updates.

AI Summary

On October 13, 2025, ASP Isotopes Inc. filed an 8-K report. The filing primarily serves as a notification of other events and includes financial statements and exhibits. No specific material events or transactions were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates that ASP Isotopes Inc. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific details of material events, risks, or financial performance.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by ASP Isotopes Inc.?

The 8-K filing indicates 'Other Events' and includes 'Financial Statements and Exhibits', suggesting it's for reporting significant events or submitting required financial documentation.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on October 13, 2025.

In which U.S. state is ASP Isotopes Inc. incorporated?

ASP Isotopes Inc. is incorporated in Delaware.

What is the SEC file number for ASP Isotopes Inc.?

The SEC file number for ASP Isotopes Inc. is 001-41555.

What is the business address of ASP Isotopes Inc. as listed in the filing?

The business address is 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

Filing Stats: 487 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-10-14 06:41:01

Key Financial Figures

Filing Documents

01. Other Events

Item 8.01. Other Events. On October 13, 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing business updates, including a supply agreement for enriched silicon-28 and an acquisition of a radiopharmacy in the United States. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference, other than the seventh, tenth and eleventh paragraphs of the press release.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated October 13, 2025, of ASP Isotopes Inc. announcing business updates, including a supply agreement for enriched silicon-28 and an acquisition of a radiopharmacy in the United States. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: October 14, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing